Filter
55
Text search:
Astra
Zeneca
Featured
Recommendations
10
New Publications
1
Language
Document type
Fact sheets
15
Studies & Reports
11
Guidelines
9
No document type
9
Resource Platforms
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
East and Southern Africa
4
Global
4
India
3
West and Central Africa
3
South Sudan
2
Germany
2
Kenya
2
Ukraine
2
Western and Central Europe
2
Congo, Democratic Republic of
1
Zambia
1
South Africa
1
Brazil
1
Colombia
1
El Salvador
1
Chile
1
South–East Asia Region
1
Paraguay
1
Africa
1
Russia
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
20
Public Health
3
Clinical Guidelines
3
Annual Report MEDBOX
1
Women & Child Health
1
Key Resources
1
Toolboxes
COVID-19
32
NCDs
8
Mental Health
7
Rapid Response
1
Caregiver
1
NTDs
1
Health Financing Toolbox
1
Malaria
1
2.0 Rapid Response
1
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr
...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del
...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re
...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Internews’ Rooted In Trust (RiT) Project tracks COVID-19-related rumors circulating among social media users and vulnerable communities in Colombia, as well as other countries around the globe. The rumors are used to inform risk communication efforts by humanitarians and public health actors, and
...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in
...
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought
...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r
...
Other disorders
Chapter H.5
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur
...
Technical Guidelines for SARS-CoV-2 Vaccination: Third version
